As Filed with the Securities and Exchange Commission on November 15, 2016
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): November 15, 2016
MONSANTO COMPANY
(Exact Name of Registrant as Specified in its Charter)
| Delaware | 001-16167 | 43-1878297 |
| State of Incorporation | (Commission File Number) | (IRS Employer Identification No.) |
800 North Lindbergh Boulevard
St. Louis, Missouri 63167
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (314) 694-1000
Not Applicable
(Former Name or Former Address, If Changed Since Last Report)
_________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations under any of the following provisions (see General Instruction A.2. below):
| [ ] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| [X] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| [ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| [ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
ITEM 7.01. Regulation FD Disclosure.
Monsanto Company (“the company”) plans to participate in meetings with investors today, and Pierre Courduroux, the company’s senior vice president and chief financial officer, will speak at the Morgan Stanley Global Chemicals and Agriculture Conference at 11:00 a.m. ET (10:00 a.m. CT) today, November 15, 2016. A webcast link for the conference is available at www.monsanto.com/investors. A copy of Mr. Courduroux’s opening remarks is furnished as Exhibit 99 hereto and incorporated herein by reference.
We are furnishing the information contained in this report, including the Exhibit, pursuant to “Item 7.01 Regulation FD Disclosure” of Form 8-K promulgated by the SEC. This information shall not be deemed to be “filed” for the purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section, unless we specifically incorporate it by reference in a document filed under the Securities Act or the Exchange Act. By filing this report on Form 8-K and furnishing this information, we make no admission as to the materiality of any information in this report, including the Exhibit.
ITEM 9.01. Financial Statements and Exhibits.
(d) Exhibits
The following exhibit is filed herewith:
| Exhibit 99 | Opening Remarks of Pierre Courduroux for the Morgan Stanley Global Chemicals and Agriculture Conference on November 15, 2016 |
_________________________________
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: November 15, 2016
| MONSANTO COMPANY | |
| By: /s/ Christopher A. Martin | |
| Name: Christopher A. Martin | |
| Title: Assistant Secretary | |
3
EXHIBIT INDEX
| Exhibit No. | Description of Exhibit | |
| 99 | Opening Remarks of Pierre Courduroux for the Morgan Stanley Global Chemicals and Agriculture Conference on November 15, 2016 | |